US 7,541,439 B2
	Thrombopoietin proteins with improved properties
Matthew Baker, Cambridge (United Kingdom); and John Watkins, Cambridge (United Kingdom)
Assigned to Merck Patent GmbH, Darmstadt (Germany)
Appl. No. 10/561,097 PCT Filed Jun. 25, 2004, PCT No. PCT/EP2004/006887 § 371(c)(1), (2), (4) Date Dec. 16, 2005, PCT Pub. No. WO2005/000891, PCT Pub. Date Jan. 06, 2005.
Claims priority of application No. 03014331 (EP), filed on Jun. 26, 2003.
Prior Publication US 2006/0160995 A1, Jul. 20, 2006
Int. Cl. C07K 19/00 (2006.01); C07K 14/52 (2006.01); A61K 38/19 (2006.01); C12N 15/19 (2006.01)

U.S. Cl. 530—387.3  [530/351; 435/69.5; 424/198.1; 424/192.1]

6 Claims

1. An isolated polypeptide comprising the amino acid residue sequence of SEQ ID NO: 6.